| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GCC.20193 |
| P698 | PubMed publication ID | 15846790 |
| P50 | author | Torsten Haferlach | Q66370751 |
| Claudia Schoch | Q66370757 | ||
| Susanne Schnittger | Q66370791 | ||
| P2093 | author name string | Alexander Kohlmann | |
| Wolfgang Kern | |||
| Wolfgang Hiddemann | |||
| P2860 | cites work | Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile | Q78409937 |
| Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping | Q80483305 | ||
| HumanCDC23:cDNA Cloning, Mapping to 5q31, Genomic Structure, and Evaluation as a Candidate Tumor Suppressor Gene in Myeloid Leukemias | Q22004153 | ||
| Multicolor Spectral Karyotyping of Human Chromosomes | Q22065566 | ||
| Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases | Q24562724 | ||
| Genetic instabilities in human cancers | Q28131826 | ||
| Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q) | Q28143169 | ||
| Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) | Q28209814 | ||
| Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial | Q30741760 | ||
| Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients | Q31892904 | ||
| Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature | Q33949925 | ||
| The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial | Q34517235 | ||
| Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis | Q34523534 | ||
| Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease | Q34524219 | ||
| Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. | Q35080478 | ||
| Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes | Q37095280 | ||
| De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19. | Q38485176 | ||
| Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH. | Q38487721 | ||
| Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. | Q38489443 | ||
| Cross-species color banding in ten cases of myeloid malignancies with complex karyotypes | Q38495027 | ||
| Karyotyping human chromosomes by combinatorial multi-fluor FISH. | Q38507389 | ||
| Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies | Q40639306 | ||
| The coloring of cytogenetics | Q40929860 | ||
| Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibit | Q44142819 | ||
| Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor | Q44171637 | ||
| Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia | Q44449269 | ||
| AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases | Q44885054 | ||
| 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop | Q46139148 | ||
| Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML | Q47414654 | ||
| Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using m‐FISH | Q49054744 | ||
| Further characterization of complex chromosomal rearrangements in myeloid malignancies: spectral karyotyping adds precision in defining abnormalities associated with poor prognosis. | Q49279882 | ||
| Dependence of age-specific incidence of acute myeloid leukemia on karyotype | Q59529896 | ||
| Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases | Q69774388 | ||
| Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia | Q71293257 | ||
| Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia | Q72399666 | ||
| Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno | Q73567637 | ||
| Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML | Q73769144 | ||
| Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors | Q74546041 | ||
| Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505) | Q74593023 | ||
| P433 | issue | 3 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| leukemia | Q29496 | ||
| karyotype | Q189967 | ||
| P304 | page(s) | 227-238 | |
| P577 | publication date | 2005-07-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
| P1476 | title | Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile | |
| P478 | volume | 43 |
| Q35921510 | A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. |
| Q56517348 | A new adult AML case with an extremely complex karyotype, remission and relapse combined with high hyperdiploidy of a normal chromosome set in secondary AML |
| Q81350350 | A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations |
| Q44771505 | AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes |
| Q58481811 | Acute Myeloid Leukemia |
| Q58481761 | Acute myeloid leukemia |
| Q36180049 | Allelic imbalances in radiation-associated acute myeloid leukemia |
| Q59603024 | Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation ( |
| Q91709978 | Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT |
| Q46577501 | Anti-leukaemic effects induced by APR-246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells |
| Q37437233 | Applications of microarray technology to Acute Myelogenous Leukemia |
| Q96585544 | Chromosomal instability upregulates interferon in acute myeloid leukemia |
| Q47574634 | Chromothripsis in acute myeloid leukemia: Biological features and impact on survival. |
| Q52374501 | Chromothripsis in acute myeloid leukemia: biological features and impact on survival |
| Q41508288 | Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group |
| Q33613785 | Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data |
| Q84505783 | Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH |
| Q36963419 | Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth |
| Q81099032 | Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping |
| Q24644654 | Cytogenetic features in myelodysplastic syndromes |
| Q36808186 | Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype |
| Q38238954 | DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance |
| Q64065541 | Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo |
| Q94544240 | Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia |
| Q89597926 | From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia |
| Q36249165 | Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel |
| Q38166364 | Genome-scale technology driven advances to research into normal and malignant haematopoiesis |
| Q36064278 | Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q). |
| Q38223490 | Genomic characterization of acute leukemias |
| Q35249211 | Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype |
| Q81422108 | Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH) |
| Q58481777 | Hyperdiploidy with 49–65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome |
| Q47416249 | Identification of novel cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers |
| Q38694866 | Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy. |
| Q79139041 | Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups |
| Q48252205 | Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities |
| Q37442649 | Interactive diagnostics in the indication to allogeneic SCT in AML. |
| Q81402320 | Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype |
| Q36866357 | Noncytotoxic Differentiation Treatment of Renal Cell Cancer |
| Q52347275 | Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis |
| Q58481820 | Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial |
| Q40381532 | Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome |
| Q33244998 | Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications |
| Q34624427 | RAD51AP1-deficiency in vertebrate cells impairs DNA replication |
| Q44510381 | Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study o |
| Q81441385 | Reply to 'The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study' by Ning et al |
| Q36996528 | SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia |
| Q36579076 | Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics |
| Q46853420 | Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A. |
| Q50629545 | TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis |
| Q39555179 | TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes |
| Q39554542 | The USP1-UAF1 complex interacts with RAD51AP1 to promote homologous recombination repair |
| Q38892311 | The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia |
| Q40009452 | The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia |
| Q37865545 | Unfavorable-risk cytogenetics in acute myeloid leukemia |
| Q102075475 | Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia |
| Q34629500 | XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia |
| Q36848202 | p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies |
Search more.